quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:15:00·1995d
PRRelease
Fennec Pharmaceuticals Inc. logo
Immunomedics, Inc. logo

Processa Pharmaceuticals Announces the Appointment of Dr. Khalid Islam to Its Board of Directors

FENC· Fennec Pharmaceuticals Inc.IMMU· Immunomedics, Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • FENC
    Fennec Pharmaceuticals Inc.
    Health Care
  • IMMU
    Immunomedics, Inc.
    Health Care

Recent analyst ratings

  • Feb 12FENCUpdateB. Riley Securities$16.00
  • Jan 9FENCUpdatePiper Sandler-
  • Nov 22FENCUpdateCantor Fitzgerald$12.00
  • Sep 7FENCUpdateCapitalOne$11.00
  • Aug 8FENCUpdateCraig Hallum$14.00

Related

  • SEC1d
    Fennec Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR2d
    Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting
  • SEC16d
    Fennec Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR16d
    Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
  • INSIDER21d
    SEC Form 4 filed by Cioffi Christiana Marie
  • INSIDER21d
    SEC Form 4 filed by Hackman Jeffrey S.
  • INSIDER21d
    SEC Form 4 filed by Raykov Rosty
  • INSIDER21d
    SEC Form 4 filed by Sayad Pierre Sargis
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022